- Home
- CHGG vs TENX Comparison
CHGG vs TENX Comparison
Compare CHGG & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHGG | TENX |
|---|---|---|
| Founded | 2005 | 1967 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 62.6M | 56.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CHGG | TENX |
|---|---|---|
| Price | $0.54 | $12.37 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $1.50 | ★ $22.50 |
| AVG Volume (30 Days) | ★ 1.6M | 208.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.44 | $4.63 |
| 52 Week High | $1.90 | $18.38 |
Technical Indicators
Market Signals| Indicator | CHGG | TENX |
|---|---|---|
| Relative Strength Index (RSI) | 28.23 | 43.75 |
| Support Level | $0.67 | $12.53 |
| Resistance Level | $0.81 | $13.32 |
| Average True Range (ATR) | 0.07 | 0.90 |
| MACD | -0.02 | -0.20 |
| Stochastic Oscillator | 4.45 | 18.89 |
Price Performance
Historical ComparisonAbout CHGG Chegg Inc.
Chegg Inc is an American educational services company. The Chegg platform provides products and services to support learners with their academic course materials, as well as their career and personal skills development. The company's service and product offerings fall into two categories: Subscription Services, which encompasses Chegg Study Pack, Chegg Study, Chegg Writing, Chegg Math, and Busuu offerings that can be accessed internationally through the company's websites and on mobile devices, and Skills and Other, which encompasses skills, advertising services, print textbooks, and eTextbooks offerings.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.